Abstract. Using fiducial markers on patient's body surface to predict the tumor location is a widely used approach in lung cancer radiotherapy. The purpose of this work is to propose an algorithm that automatically identifies a sparse set of locations on the patient's surface with the optimal prediction power for the tumor motion. In our algorithm, it is assumed that there is a linear relationship between the surface marker motion and the tumor motion. The sparse selection of markers on the external surface and the linear relationship between the marker motion and the internal tumor motion are represented by a prediction matrix. Such a matrix is determined by solving an optimization problem, where the objective function contains a sparsity term that penalizes the number of markers chosen on the patient's surface. Bregman iteration is used to solve the proposed optimization problem. The performance of our algorithm has been tested on realistic clinical data of four lung cancer patients. Thoracic 4DCT scans with 10 phases are used for the study. On a reference phase, a grid of points are casted on the patient's surface (except for patient's back) and propagated to other phases via deformable image registration of the corresponding CT images. Tumor locations at each phase are also manually delineated. We use 9 out of 10 phases of the 4DCT images to identify a small group of surface markers that are most correlated with the motion of the tumor, and find the prediction matrix at the same time. The 10th phase is then used to test the accuracy of the prediction. It is found that on average 6 to 7 surface markers are necessary to predict tumor locations with a 3D error of about 1mm. It is also found that the selected marker locations lie closely in those areas where surface point motion has a large amplitude and a high correlation with the tumor motion. Our method can automatically select sparse locations on patient's external surface and estimate a correlation matrix based on 4DCT, so that the selected surface locations can be used to place fiducial markers to optimally predict internal tumor motions.
Introduction
Modern radiotherapy techniques, such as Intensity Modulated Radiation Therapy (IMRT), are capable of delivering highly conformal radiation dose to a cancerous target while sparing critical structures and normal tissues. Intra-fraction tumor motion caused by patient respiration, however, may lead to geometric miss of the target and hence 5 potentially compromise the efficacy of these techniques while treating tumors at lung or upper abdomen area. To mitigate this problem, a number of techniques have been developed, such as gated treatment, for which accurate modeling and prompt prediction of tumor motion are necessary (Jiang, 2006b; Jiang, 2006a) .
Tumor localization methods can be generally categorized according to the locations 10 of surrogates. Methods using internal surrogates, such as gold markers implanted in or near tumor, are accurate but have issues like the risks of pneumothorax for lung cancer patients (Arslan et al., 2002; Geraghty et al., 2003) , marker migration (Nelson et al., 2007) , and the extra imaging radiation dose (Jiang, 2006b) . In contrast, external surrogate based tumor localization is usually noninvasive and radiation free. In such 15 methods, a regression model is first built between the coordinates of some empirically selected external surrogates and those of the tumor using a training data set. Such a model will be utilized to predict the tumor location using the real-time measurements of the marker locations during a treatment via, for example, Cyberknife Synchrony system (Accuray Corporate, Sunnyvale, CA, USA) (Pepin et al., 2011 ). Yet, the accuracy of this 20 method usually relies on the correlation between external marker motion and internal tumor motion for a particular patient (Hoisak et al., 2004) . In fact, there are a few questions one should keep in mind while using external markers for tumor tracking. First of all, how many external markers are necessary? While using more markers may potentially provide more comprehensive information for 25 tumor location estimation, it is evident that the motion of points on a patient surface is strongly correlated and information from many surface markers is likely to be redundant. Clinically, it is necessary and desirable to use a minimum number of markers to predict the tumor motion to a satisfactory degree. Second, given the number of markers, where shall we optimally place them? Despite a lot of studies regarding the patient breathing 30 pattern and the selection of marker locations (Yan et al., 2006; Wu et al., 2008) , markers are placed empirically in most clinical practice.
In this study, we will attempt to answer the aforementioned two questions utilizing a sparse optimization approach. Specifically, our objective is to choose a sparse set of points from all the points on the front surface of a patient, so that a linear motion model 35 yields the smallest error in tumor location prediction. With a novel optimization model to formulate this objective in a clean and precise mathematical language, as well as an effective numerical algorithm to solve the problem, we can effectively yet efficiently identify the key surface points used to predict tumor motion. A linear regression model is also developed during the optimization process, such that those markers collaboratively 40 predict tumor locations to a satisfactory extent.
Methods and Materials
We start with an introduction of some notations. Denote Y ∈ R 3×m as a 3 × m matrix whose column vectors are the three Cartesian coordinates of the center of the tumor at various times t j with j = 1, 2, . . . , m. Suppose there are k candidate 45 surface points available for tumor motion prediction. We denote the coordinates of the collection of all of those surface points at a given time t j as a column vector
T , where each vector
.., k contains three entries corresponding to the three Cartesian coordinates of the point i.
If we assemble all the collections of markers X j associated with different time t j , we will 50 have the following matrix X :
Optimization Model
Assume, for simplicity, there is a linear motion model that relates the external marker motion and the tumor motion. Mathematically speaking, there exist a matrix A ∈ R 3×3k such that AX ∼ Y . Note that the columns of the matrix A can be also associated to 55 those k surface points, each with three coordinates. If one column of the matrix A is non-zero, the corresponding coordinate for that surface point is then utilized to predict the tumor motion. As it is our purpose to select only a few surface points for tumor motion prediction, the problem can be casted as finding a matrix A with only a few non-vanishing columns, such that the motion of tumor recorded in Y can be accurately 60 characterized by AX. Although this is simply a linear motion prediction model, our numerical experiments indicate that such an assumption is reasonable and leads to accurate tumor location estimations. We shall refer to the problem of optimal marker selection as the problem of finding the linear dependence of the motion of the internal tumor with the motion of some sparsely selected markers.
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We propose our optimal marker selection model as follows:
where
In this optimization problem, the objective function is defined in such a way that it groups all the matrix elements in a column of A utilizing an 2 -norm and then takes 1 -norm among all columns.
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Minimizing such an objective function term enables us to enforce sparsity at only the level of matrix columns. This idea is inspired by that of compressed sensing Candes and Tao, 2005; Donoho, 2006) , which is a recent revolutionary concept in information theory. The applications of such a 2,1 norm has been recently explored in many problems, such as beam orientation optimization 75 for IMRT (Jia et al., 2011) , to effectively select only a few groups of elements. Similar idea was also used in (Esser et al., 2011) where the 1,∞ norm was used for matrix factorization with applications in hyperspectral image unmixing. We remark that the model (1) not only sparsely selects markers needed to track the motion of an internal tumor, but also provides the linear dependence of the motion of the selected markers 80 with that of the tumor at the same time. All such information is integrated within the solution matrix A.
Fast Numerical Algorithm
To solve the proposed optimization problem (1), we use a Bregman distance-based algorithm proposed by Yin et. al. (Yin et al., 2008) , which is proven to be efficient for 85 1 minimization problems. Given matrices X and Y , the fast algorithm that solves (1) can be written into an iterative form as:
where k is the iteration index and · F is the Frobenius norm. The optimization problem in the first subproblem of (2) can be solved using the proximal forward-90 backward splitting algorithm (Combettes and Wajs, 2006; Hale et al., 2007) , which by itself is an iterative algorithm as:
where p is the iteration index in this subproblem and T µ (B), for a given matrix
We note that (Donoho, 1995; Wang et al., 2007) T µ (B) is the closed form solution to min
F . For computation efficiency, we shall not solve the 95 subproblem (2) accurately by using numerous iterations of (3), but only use one iteration instead. Now, applying (3) (with only one iteration) to (2), we have the following fast algorithm that solves (1) (also known as the Bregmanized operator splitting algorithm (Zhang et al., 2010) ):
Algorithm 1 Optimal Marker Selection Algorithm
Step 0. Initialization:
while stopping criteria is not satisfied do
Step 1.
Step 2.
The proof of the mathematical properties of this algorithm, such as convergence,
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is beyond the scope of this paper. Interested readers can consult references for more details (Yin et al., 2008; Zhang et al., 2010) .
For realistic patient data, because of the presence of noise and the fact that the motion of internal tumor is only approximately linearly dependent on the external markers, we should not expect the relative residual A k X −Y F / Y F decrease to 0. In fact, numerically we observe that the relative residual should have a lower bound whose value depends on X and Y and it is very difficult to estimate beforehand. Therefore, we adopt the following stopping criteria:
In other words, we fix an 1 as a satisfactory amount for the residual; meanwhile, if such residual is not attainable, we will terminate the algorithm when A k is not changing too much according to the tolerance 2 . 
Patient Data
To validate our algorithm with realistic clinical cases, 4DCT scan data of four lung cancer patients is used. For those patients, a four-slice GE LightSpeed CT scanner (GE Medical Systems, Milwaukee, WI, USA) was used to acquire the 4DCT data for treatment simulation. Each axial CT slice has a thickness of 2.5mm and the 4DCT 110 was obtained using respiratory signals from the Varian RPM system (Varian Medical Systems, Inc., Palo Alto, CA, USA). The 4DCT scan consists of ten different phases of one breathing cycle; and the CT volume at each respiratory phase consists of 100 to 144 slices of CT images covering the most of thorax area depending on patients. Each slice of CT image has 512 × 512 pixels, with a pixel size of 0.977 × 0.977mm 2 . For each 115 patient, tumor GTV was manually contoured on 4DCT scan images of ten respiratory phases by an expert observer and the 3D tumor center coordinates were identified. Table 1 summarizes the number of CT image slices for each CT image volume and the average tumor motion amplitude in the superior-inferior(S-I) direction and average surface motion amplitude for each patient. It can be observed that the average tumor 120 motion amplitude in the S-I direction range from 3.3mm to 9.0mm. The average surface point motion amplitude ranges among all the patients are found to be 0.8mm to 2.0mm.
Patient No. of slices Tumor motion amplitude in S-I (mm)
Average surface motion amplitude (mm) 1 144 6.3 2.0 2 100 9.0 1.5 3 132 7.4 1.8 4 104 3.3 0.8 Table 1 . Summary of patient data with number of CT slices, average tumor motion amplitude in S-I direction, and average surface motion amplitude for each patient.
Meanwhile, the external surfaces of each patient, excluding the patient's back, at each phase are extracted by segmenting the CT images using a simple threshold method.
For each patient, the CT image volume at the end of inhale is set as the target image; 125 the other nine CT image volumes, corresponding to the other nine different respiratory phases, are set as moving images. The correspondence between surfaces at different phases is established by deformable image registration (Thirion, 1998; Gu et al., 2010) . When surface points are available on the external surfaces of each patient, we further sub-sampled the point sets uniformly to reduce the total number of candidate points 130 for a better computational efficiency. In our experiments, we choose approximately 200 candidate surface points for each patient.
Validation
To validate our marker selection algorithm, we employ an leave-one-out cross validation (LOOCV) method. Specifically, 10 tests are performed for a patient, and for each test,
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we single out one of the 10 respiratory phases and use the other 9 to form the matrix Y and solve for the matrix A using Algorithm 1. We then validate our method by using the matrix A to predict the location of the tumor at the phase that has been singled out. The deviation of the predicted tumor location from the actual tumor location is characterized by the 3D Euclidean distance between them in mm.
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The patients' 4DCT image volumes cover a complete breathing cycle, hence contain information of external surface motion. We could in principle identify regions of interest (ROIs) on the patient surface that strongly correlate with tumor motions. It is expected that the marker locations selected by Algorithm 1 should fall closely into those ROIs. This also serves as a criterion for the justification of the correctness of our marker 145 selection algorithm. To select the ROI, we consider the following two metrics. First, from the deformation vector fields between different respiratory phases, the motion trajectory for all surface points were extracted. The correlation function between the internal tumor motion in the S-I direction and the motion vector of each point on the external surface was employed as a metric. However, only part of the external surface 150 has considerable motion amplitude and those points with small motion amplitude should not be considered for predicting tumor motions despite their possible high correlations with tumor S-I motion. Therefore, we only focus on the surface region with large motion amplitudes. Combining the two criteria, we define the ROI as the areas on the surface in which the motion amplitude is larger than 80% of the maximum value and 155 the correlation is above 0.85. Although those threshold values for the two criteria are chosen empirically, the general conclusions presented in the rest of this paper are found not sensitive to them.
Results

Marker selection
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We have studied the validation of our surface marker selection algorithm on 4 lung cancer patients. The selected 6 surface markers in one typical patient (patient No. 4) Figure 1 . Left: Markers selected by our algorithm are shown as red circles on one of the patient's surface. Right: the LOOCV results for the same patient using the phases 1 through 9 as training data (blue dots) and the phase 10 as the testing data (red dot). The red circle is the predicted tumor location.
are drawn in 3D space on the patient surface, as shown in the left panel of Fig. 1 . Meanwhile, in the right panel of Fig. 1 , we demonstrate the LOOCV results for the same patient using the phases 1 through 9 as training data and the phase 10 as the 165 testing data. Specifically, the blue dots are the locations of the tumor in the training phases and the red dot is the location of the tumor at the phase 10. The red circle is the predicted location using the selected surface markers and the matrix A. The 3D distance between the true tumor location and the predicted location is 0.83mm, indicating the great capability for tumor motion prediction of our algorithm. Table 2 . Summary of tumor location prediction errors, the numbers of markers selected, and the computation time.
A summary of the results of all 10 tests for each of the 4 patients is given in Table 2 . For each patient, we compute the mean and the standard deviation of the 3D errors for the predicted tumor locations and the number of selected markers over all the 10 tests in the LOOCV. It is found that, on average, our algorithm can automatically select about 6 surface markers that collaboratively predict tumor motion with an 3D error 175 about 1mm.
Algorithm 1 is implemented using MATLAB on a laptop with Intel Core i7 (1.73 GHz) CPU and 8.0G RAM. As for the computation time, it is found that the average time required to perform one optimization is about 14sec. We emphasize that the time reported here is the one for marker selection. Once the markers are selected, the matrix A becomes available. The prediction of tumor motion using selected markers only requires a simple matrix multiplication and hence the prediction can be achieved in a negligible amount of computation time. From Table 2 , it is also found that the computational time for marker selection varies from case to case, which is possibly ascribed to the different patient sizes. 
Comparison with ROI
The correlation between the internal tumor motion in the S-I direction and the external surface motion is shown on Fig. 2. In Fig. 3 , we also present the amplitude of external surface motion. Combining the correlation map and the motion amplitude map, the ROIs for each patient can be identified, shown as red regions in Fig. 4 , where the ROIs 190 have correlation coefficients larger than 0.85 and surface motion amplitude greater than 80% of the maximum value. Apparently, the ROIs are highly dependent on different breathing motion patterns among patients. We also plot in Fig. 4 the locations of markers selected with our algorithm. We can see that most of the marker positions selected by our algorithm fall inside or close to the ROIs, which indicate the robustness 195 of our algorithm. 
Conclusions
In this paper, we proposed a novel mathematical model to automatically determine the optimal number and locations of fiducial markers on patient's surface for predicting lung tumor motion. We also introduced an efficient numerical algorithm for solving 200 the proposed model. Experiments on the 4DCT data of 4 lung cancer patients have shown that, by using our method, usually 6-7 markers are selected on patient's external surface. Most of these markers are in the regions where the surface motion is relatively large and the correction between the surface motion and the internal tumor motion is relatively high. Using these markers, the lung tumor positions can be predicted with an 205 average 3D error of approximately 1mm. Both the number of markers and the prediction accuracy are clinically acceptable, indicating that our method can be used in clinical practice.
